HIV prevention
Coverage of HIV prevention in the Nexus archive.
- CDC funding shift puts $450K in Twin Cities HIV prevention at risk, group says
The CDC's decision to stop renewing funding for community-based HIV programs in Minnesota threatens $450,000 annually for the Aliveness Project's HIV testing, outreach, and treatment services. The organization warns the funding shift to the Minnesota Department of Health could disrupt prevention efforts, despite having provided over 6,000 HIV tests and linked 96% of positive cases to medical care within a month.
- US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
A report reveals that disruptions to the U.S. PEPFAR program under the Trump administration caused clinic closures, staff layoffs, and reduced HIV services in 46 countries. Over 1,700 clinics and 16,000 staff positions were lost, with cuts disproportionately affecting vulnerable groups like sex workers and transgender people.
- US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
The Trump administration’s disruptions to the President’s Emergency Plan for AIDS Relief (PEPFAR) caused clinic closures, staff layoffs, and reduced HIV services in 46 countries. A report by amfAR found that over 1,700 clinics closed and 16,000 staff members were lost, with severe cuts to prevention programs and services for high-risk populations like sex workers and people who inject drugs.
- South Africa: Gauteng Health Exceeds Lenacapavir Rollout Targets
The Gauteng Department of Health (GDoH) has surpassed its targets for the Lenacapavir rollout programme in its first month, marking a significant milestone in the distribution of the HIV prevention drug.
- S.F. supervisors finalize budget after unusually quick negotiations
San Francisco supervisors finalized a budget that reversed cuts to Free City College, HIV prevention, senior services, and other programs. The budget was agreed upon after unusually quick negotiations.
- Africa: 'One Injection Protects Up to Six Months' - What Is New HIV Drug Lenacapavir?
South Africa has become the ninth African country to introduce the long-acting HIV prevention drug lenacapavir, which offers protection for up to six months. Experts are discussing its mechanism, supply-demand concerns, and challenges in developing an HIV vaccine.
- South Africa: Did US Aid Cuts Break Precisely the Things We Need Most for the Lenacapavir Rollout?
South Africa launched a new six-monthly HIV prevention injection, but infrastructure for HIV services has been dismantled due to U.S. aid cuts. The article questions whether the new technology can be successfully delivered without the previously established pathways.